These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2885139)

  • 1. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects.
    Tselepis AD; Evangelou A; Tsoukatos D; Demopoulos CA; Kapoulas VM
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 87(1):41-6. PubMed ID: 2885139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice.
    Kelefiotis D; Lanara E; Vakirtzi-Lemonias C; Siafaka A; Mavris M; Lazanas M; Demopoulos CA
    Life Sci; 1988; 42(6):623-33. PubMed ID: 3339951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
    McManus LM; Pinckard RN; Fitzpatrick FA; O'Rourke RA; Crawford MH; Hanahan DJ
    Lab Invest; 1981 Oct; 45(4):303-7. PubMed ID: 7300244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGEPC, a vasodilator phospholipid with profound circulatory actions.
    Sybertz EJ; Watkins RW; Vemulapalli S; Baum T; Chiu PJ; Barnett A
    Prog Clin Biol Res; 1986; 219():133-56. PubMed ID: 3538024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.
    Halonen M; Palmer JD; Lohman IC; McManus LM; Pinckard RN
    Am Rev Respir Dis; 1980 Dec; 122(6):915-24. PubMed ID: 7458063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of the responsiveness to intravenous platelet-activating factor.
    Angle MJ; Pinckard RN; Showell HJ; McManus LM
    Lab Invest; 1987 Sep; 57(3):321-8. PubMed ID: 3626521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.
    Kenzora JL; Pérez JE; Bergmann SR; Lange LG
    J Clin Invest; 1984 Oct; 74(4):1193-203. PubMed ID: 6480824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary and intravascular alterations during the sustained infusion of PAF.
    Deavers SI; Arroyave JM; Prihoda TJ; McManus LM
    J Lipid Mediat; 1991; 4(2):145-63. PubMed ID: 1954334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit.
    McManus LM; Fitzpatrick FA; Hanahan DJ; Pinckard RN
    Immunopharmacology; 1983 Feb; 5(3):197-207. PubMed ID: 6832960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs.
    Demopoulos CA; Tsabikakis GE; Kapoulas VM
    Immunol Lett; 1981 Aug; 3(3):133-5. PubMed ID: 7287060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkyl chain homologs of platelet-activating factor and their effects on the mammalian heart.
    Levi R; Genovese A; Pinckard RN
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1341-7. PubMed ID: 2742592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of hepatic calcium pools by platelet activating factor.
    Lapointe DS; Hanahan DJ; Olson MS
    Biochemistry; 1987 Mar; 26(6):1568-74. PubMed ID: 3593678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function.
    Halonen M; Lohman IC; Dunn AM; McManus LM; Palmer JD
    Am Rev Respir Dis; 1985 Jan; 131(1):11-7. PubMed ID: 3881060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic inhibition of AGEPC-stimulated Na+/Ca2+ exchange and AGEPC-induced platelet activation.
    Kester M; Fisher RA; Olson MS
    Biochim Biophys Acta; 1989 Nov; 1014(2):195-202. PubMed ID: 2554977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet-activating factor on coronary circulation of the domestic pig.
    Feuerstein G; Boyd LM; Ezra D; Goldstein RE
    Am J Physiol; 1984 Mar; 246(3 Pt 2):H466-71. PubMed ID: 6703081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes.
    Gorman RR; Morton DR; Hopkins NK; Lin AH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():57-63. PubMed ID: 6303092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium.
    Hill CE; Olson MS
    Biochem J; 1987 Oct; 247(1):207-14. PubMed ID: 3689345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.